A CR(I)MP in the optic nerve: Recognition and implications of paraneoplastic optic neuropathy

Journal of Neuro-Ophthalmology

Volumn 26, Issue 3, 2006, Pages 165-167

  Calvert, Preston C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN; CORTICOSTEROID; FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE;

ANTIGEN EXPRESSION; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EDITORIAL; ELECTROPHYSIOLOGY; ELECTRORETINOGRAPHY; HUMAN; NEUROLOGIC DISEASE; OPTIC NERVE; OPTIC NERVE DISEASE; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RETINOPATHY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

HUMANS; NERVE TISSUE PROTEINS; OPTIC NERVE; OPTIC NERVE DISEASES; PARANEOPLASTIC POLYNEUROPATHY;

EID: 33748685047     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wno.0000235567.73389.c3     Document Type: Editorial

References (14)

1. Cross SA, Salamao DR, Parisi JE, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 2003;54:38-50.
2. Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 1999;117:471-7.
3. Matsui Y, Mehta MC, Katsumi O, et al. Electrophysiological findings in paraneoplastic retinopathy. Graefes Arch Clin Exp Ophthalmol 1992;230:324-8.
4. Alexander KR, Fishman GA, Peachey NS, et al. 'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 1992;33:477-83.
5. Pillay N, Gilbert JJ, Ebers GC, et al. Internuclear ophthalmoplegia and 'optic neuritis': paraneoplastic effects of bronchial carcinoma. Neurology 1984;34:788-91.
6. Boghen D, Sebag M, Michaud J. Paraneoplastic optic neuritis and encephalomyelitis. Report of a case. Arch Neurol 1988;45:353-6.
7. Malik S, Furlan AJ, Sweeney PJ, et al. Optic neuropathy: a rare paraneoplastic syndrome. J Clin Neuroophthalmol 1992;12: 137-41.
8. De la Sayette V, Bertran F, Honnorat J, et al. Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor. Arch Neurol 1998;55: 405-8.
9. Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma related autoimmunity. Ann Neurol 2001;49:146-54.
10. Sheorajpanday R, Slabbynck H, Van De Sompel W, et al. Small Cell Lung Carcinoma Presenting as Collapsin Response-Mediating Protein (CRMP) -5 Paraneoplastic Optic Neuropathy. J Neuroophthalmol 2006;26:168-172.
11. Asproudis IC, Nikas AN, Psilas KG. Paraneoplastic optic neuropathy in a patient with a non-small cell lung carcinoma: a case report. Eur J Ophthalmol 2005;15:420-3.
12. Luiz JE, Lee AG, Keltner JL, et al. Paraneoplastic optic neuropathy and autoantibody production in small-cell carcinoma of the lung. J Neuroophthalmol 1998;18:178-81.
13. Paraneoplastic autoantibody evaluation, serum. Mayo Medical Laboratories Test Catalog. [database on the Internet]. Rochester, MN: Mayo Foundation, Mayo Medical Laboratories; 2000-2001. Available at: http://216.245.161.151/TestView. aspx?testID=9722. Accessed June 5, 2006.
14. Waterston JA, Gilligan BS. Paraneoplastic optic neuritis and external ophthalmoplegia. Aust N Z J Med 1986;16:703-4.